Amplicore
About:
Amplicore is a biotechnology company.
Website: https://www.amplicorepharma.com/
Top Investors: ITIC: Industrial Technology Investment Corporation, Berkeley Catalyst Fund (BCF), Photon Fund, SVE Capital
Description:
Amplicore is a develop injectable therapeutics for degenerative musculoskeletal disorders to serve unmet medical needs. They take a regenerative approach to joint osteoarthritis, cartilage damage, degenerative disc disease, and acute meniscus tears.
Total Funding Amount:
$4M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Ohio, Illinois, United States
Founded Date:
2019-02-01
Founders:
Chia-Ying Lin
Number of Employees:
1-10
Last Funding Date:
2021-03-25
IPO Status:
Private
Industries:
© 2025 bioDAO.ai